Online Shop
Abacavir
Aceclofenac
Acyclovir
Adefovir
Alfuzosin
Amiloride
Amlodipine
Amoxycillin
Anastrozole
Atropine
Azathioprine
Azithromycin
Baclofen
Bencyclane
Bicalutamide
Bisacodyl
Bisoprolol
Bosentas
Brimonidine
Butenafine
Calcitriol
Capecitabine
Cefixime
Cefoperazone
Cefotetan
Clindamycin
Clobetasone
Clonidine
Cyclosporine
Cyclosporine
Dacarbazine
Desonide
Dextroamphetamine
Didanosine
Duloxetine
Dutasteride
Efavirenz
Emtricitabine
Estradiol
Etoricoxib
Felodipine
Fenofibrate
Finasteride
Flucloxacillin
Fluvoxamine
Formoterol
Formoterol-Budesonide
Gliclazide
Goserelin
Hepatitis
Hyaluronate
Hydrocortisone
Hydroxyurea
Hypromellose
Indinavir
Insulin
Irinotecan
Isotretinoin
Itopride
Ketoconazole
Lamivudine
Levosalbutamol
Linezolid
Lisinopril
Lopinavir
Mercaptopurine
Mesalazine
Mometasone
Mycophenolate
Nateglinide
Nebivolol
Nelfinavir
Nevirapine
Nitrendipine
Olmesartan
Ondansetron
Ormeloxifene
Ornidazole
Orphenadrine
Oseltamivir
Oxcarbazepine
Oxybutynin
Oxytetracycline
Paracetamol
Paracetamol
Piroxicam
Progestin
Propranolol
Pyrantel
Quetiapine
Rabeprazole
Ranolazine
Risedronate
Rizatriptan
Rosiglitazone
Salbutamol
Saquinavir
Sildenafil
Sorbitol
Sucralfate
Tamsulosin
Telmisartan
Tenofovir
Tobramycin
Torsemide
Venlafaxine
Voriconazole
Warfarin
Zolmitriptan

Abacavir.

Structure

- 300 mg as Abacavir sulfate

Without a Prescription

Abacavir 300 mg tablets are prescribed for the treatment of HIV-1 infection in combination with other antiretroviral agents.
Additional important information on the use of Abacavir for treatment of HIV-1 infection:
Abacavir is one of multiple products containing abacavir.
Before starting Abacavir, review medical history for prior exposure to any abacavir containing product in order to avoid reintroduction in a patient with a history of hypersensitivity to abacavir.

Dosage

Abacavir may be taken with or without food.
Adults:
Abacavir recommended dose for adults is:
600 mg once daily in combination with other antiretroviral agents or 600 mg daily administered as either 300 mg twice daily.

Patients with Hepatic Impairment:
Abacavir recommended dose in patients with mild hepatic impairment is 200 mg twice daily. To enable dose reduction, Abacavir(10 mL twice daily) should be prescribed for the treatment of these patients. The safety, efficacy, and pharmacokinetic properties of Abacavir have not been established in patients with moderate to severe hepatic impairment, and therefore Abacavir is contraindicated in these patients.

Contraindications

Abacavir tablets are contraindicated in patients with:
- Moderate or severe hepatic impairment;
- Previously demonstrated hypersensitivity to abacavir;
- Never restart Abacavir or any other abacavir-containing product following a hypersensitivity reaction to abacavir;

Form

Container of 30 tablets

Prescription drugs without a script
Prescription drugs no script
Prescription drugs no prescription
Prescription drugs without a prescription
RX no RX
RX without RX
2004 - 2017